Chemed Corp (CHE) earnings
CHE earnings moved a median of +0.20% by the close. Quarterly and annual CHE reports and results, each read against the price at its own news timestamp. Back to the CHE overview →
37 measured CHE earnings events.
Where these CHE earnings landedvs 37 measured CHE earnings reactions
| Middle 50% of CHE earnings reactions | -0.71% to +1.11% |
|---|---|
| Median reaction (to close) | +0.20% |
| Measured reactions | 37 |
Point-in-time · zero look-ahead
Half of the 37 CHE earnings events with a measured close landed between -0.71% and +1.11%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28 | Press release | +0.20% | -0.40% | |
| Form 10-Q CHEMED CORP For: Jun 30 | SEC filing · Form 10-Q | -0.35% | +0.00% | |
| Chemed Reports Second-Quarter 2026 Results | Press release | +1.89% | +3.14% | |
| Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29 | Press release | -0.19% | +2.37% | |
| Form 10-Q CHEMED CORP For: Mar 31 | SEC filing · Form 10-Q | +0.31% | -1.16% | |
| Chemed Reports First-Quarter 2026 Results | Press release | +1.15% | -5.26% | |
| Chemed To Report First Quarter 2026 Earnings April 23, Related Conference Call To Be Held On April 24 | Press release | -0.02% | -0.56% | |
| Form 10-K CHEMED CORP For: Dec 31 | SEC filing · Form 10-K | +0.35% | +3.74% | |
| Chemed Reports Fourth-Quarter 2025 Results | Press release | +1.00% | -1.08% | |
| Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26 | Press release | — | -0.23% | |
| Form 10-Q CHEMED CORP For: Sep 30 | SEC filing · Form 10-Q | +0.80% | -4.44% | |
| Chemed Reports Third-Quarter 2025 Results | Press release | +1.01% | +8.39% | |
| Chemed To Report Third-Quarter 2025 Earnings October 28, Related Conference Call To Be Held On October 29 | Press release | +0.20% | +0.49% | |
| Form 10-Q CHEMED CORP For: Jun 30 | SEC filing · Form 10-Q | -0.00% | -0.12% | |
| Chemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure | Press release | +0.10% | -0.71% | |
| Chemed To Report Second-Quarter 2025 Earnings July 29, 2025 | Press release | -1.96% | -3.08% | |
| Form 10-Q CHEMED CORP For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.77% | |
| Chemed Reports First-Quarter 2025 Results | Press release | -3.56% | -3.17% | |
| Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24 | Press release | +0.00% | -0.21% | |
| Form 10-K/A CHEMED CORP For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.25% | |
| Form 10-K CHEMED CORP For: Dec 31 | SEC filing · Form 10-K | +0.00% | +3.02% | |
| Chemed Reports Fourth-Quarter 2024 Results | Press release | -0.70% | +3.01% | |
| Chemed To Report Fourth-Quarter 2024 Earnings February 26, Related Conference Call To Be Held On February 27 | Press release | -0.17% | -0.26% | |
| Form 10-Q CHEMED CORP For: Sep 30 | SEC filing · Form 10-Q | -0.60% | -1.14% | |
| Chemed Reports Third-Quarter 2024 Results | Press release | -5.03% | -9.95% | |
| Chemed To Report Third-Quarter 2024 Earnings October 29, Related Conference Call To Be Held On October 30 | Press release | +0.10% | +0.20% | |
| Form 10-Q CHEMED CORP For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.86% | |
| Chemed Reports Second-Quarter 2024 Results | Press release | -0.14% | +1.11% | |
| Chemed To Report Second-Quarter 2024 Earnings July 24, Related Conference Call To Be Held On July 25 | Press release | — | -0.28% | |
| Form 10-Q CHEMED CORP For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.81% | |
| Chemed Reports First-Quarter 2024 Results | Press release | +1.88% | +0.72% | |
| Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25 | Press release | +0.26% | +0.33% | |
| Form 10-K CHEMED CORP For: Dec 31 | SEC filing · Form 10-K | — | -1.42% | |
| Chemed Reports Fourth-Quarter 2023 Results | Press release | +1.78% | +2.25% | |
| Chemed To Report Fourth-Quarter 2023 Earnings February 27, Related Conference Call To Be Held On February 28 | Press release | -0.01% | +1.03% | |
| Form 10-Q CHEMED CORP For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +1.28% | |
| Chemed Reports Third-Quarter 2023 Results – Increases Full Year Guidance | Press release | +1.88% | +4.96% |
Keep exploring
More CHE: analyst actions → · SEC filings → · CHE overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | 290 | -0.23% | 46% |
| Accuray Incorporated (ARAY) | 288 | 0.00% | 51% |
| Fate Therapeutics, Inc. (FATE) | 287 | -0.76% | 39% |
| RenovaCare, Inc. (RCAR) | 286 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.